Catalyst Wire Dossier Catalyst Wire Dossier

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

Dexmedetomidine hydrochloride in 0.9% sodium chloride · Baxter Healthcare Company
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, covering 2017-09-19 to 2024-11-06. Get the full timeline:

Most recent: FDA Approved: DEXMEDETOMIDINE HYDROCHLORIDE — Supplemental Application (Baxter Healthcare Company)

See pricing